Miloš D. Ikonomović

13.9k total citations · 3 hit papers
162 papers, 9.0k citations indexed

About

Miloš D. Ikonomović is a scholar working on Physiology, Psychiatry and Mental health and Molecular Biology. According to data from OpenAlex, Miloš D. Ikonomović has authored 162 papers receiving a total of 9.0k indexed citations (citations by other indexed papers that have themselves been cited), including 97 papers in Physiology, 43 papers in Psychiatry and Mental health and 42 papers in Molecular Biology. Recurrent topics in Miloš D. Ikonomović's work include Alzheimer's disease research and treatments (95 papers), Dementia and Cognitive Impairment Research (41 papers) and Neuroscience and Neuropharmacology Research (38 papers). Miloš D. Ikonomović is often cited by papers focused on Alzheimer's disease research and treatments (95 papers), Dementia and Cognitive Impairment Research (41 papers) and Neuroscience and Neuropharmacology Research (38 papers). Miloš D. Ikonomović collaborates with scholars based in United States, Japan and United Kingdom. Miloš D. Ikonomović's co-authors include Steven T. DeKosky, Elliott J. Mufson, Eric E. Abrahamson, William E. Klunk, Chester A. Mathis, Stephen D. Ginsberg, David M. Armstrong, Sam Gandy, Manik L. Debnath and Stephen R. Wisniewski and has published in prestigious journals such as New England Journal of Medicine, Journal of Biological Chemistry and Journal of Neuroscience.

In The Last Decade

Miloš D. Ikonomović

155 papers receiving 8.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Post-mortem correlates of in vivo PiB-PET amyloid imaging in a typical case of Alzheimer's disease

2008 681 citations Miloš D. Ikonomović, William E. Klunk et al. profile →
Upregulation of choline acetyltransferase activity in hippocampus and frontal cortex of elderly subjects with mild cognitive impairment

2002 560 citations Steven T. DeKosky, Miloš D. Ikonomović et al. Annals of Neurology profile →
Validating novel tau positron emission tomography tracer [F‐18]‐AV‐1451 (T807) on postmortem brain tissue

2015 450 citations William E. Klunk, Chester A. Mathis et al. Annals of Neurology profile →

Peers

Countries citing papers authored by Miloš D. Ikonomović

Since Specialization

Citations

This map shows the geographic impact of Miloš D. Ikonomović's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Miloš D. Ikonomović with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Miloš D. Ikonomović more than expected).

Fields of papers citing papers by Miloš D. Ikonomović

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Miloš D. Ikonomović. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Miloš D. Ikonomović. The network helps show where Miloš D. Ikonomović may publish in the future.

Co-authorship network of co-authors of Miloš D. Ikonomović

This figure shows the co-authorship network connecting the top 25 collaborators of Miloš D. Ikonomović. A scholar is included among the top collaborators of Miloš D. Ikonomović based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Miloš D. Ikonomović. Miloš D. Ikonomović is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Treatment‐related amyloid clearance (TRAC): a framework to characterize patients in the era of anti‐amyloid therapies 2025 ·Alzheimer s & Dementia ·Renaud La Joie, Jeffrey L. Cummings, Jeffrey L. Dage, Douglas Galasko, Miloš D. Ikonomović, Thomas K. Karikari, Susan Landau, Jorge J. Llibre‐Guerra, Catherine J. Mummery, Rik Ossenkoppele, Julie C. Price, Shannon L. Risacher, Ruben Smith, Christopher H. van Dyck, Marı́a C. Carrillo	2
2	Impact of racialization on neuroimaging and plasma biomarkers of Alzheimer's disease 2025 ·Alzheimer s & Dementia ·Alexandra Gogola, Xuemei Zeng, (unknown), (unknown), Anum Saeed, Brian J. Lopresti, Beth E. Snitz, Dana Tudorascu, Davneet Minhas, Miloš D. Ikonomović, Julia Kofler, (unknown), Tharick A. Pascoal, Howard Aizenstein, (unknown), Kaj Blennow, Oscar L. López, Victor L. Villemagne, Thomas K. Karikari, Ann D. Cohen	0
3	Structure–Activity Relationships and Evaluation of 2-(Heteroaryl-cycloalkyl)-1H-indoles as Tauopathy Positron Emission Tomography Radiotracers 2025 ·Journal of Medicinal Chemistry ·Jeffrey S. Stehouwer, Guofeng Huang, (unknown), Manik L. Debnath, (unknown), Steven J. Geib, Brian J. Lopresti, Miloš D. Ikonomović, N. Scott Mason, Robert H. Mach, Chester A. Mathis	1
4	Large‐scale validation of an improved and resource‐saving immunoprecipitation‐mass spectrometry assay for plasma amyloid‐β biomarkers in Alzheimer's disease 2024 ·Alzheimer s & Dementia ·(unknown), Xuemei Zeng, (unknown), Anuradha Sehrawat, (unknown), William E. Klunk, Miloš D. Ikonomović, Tharick A. Pascoal, Kirk I. Erickson, Victor L. Villemagne, Ann D. Cohen, Nathan A. Yates, Irene Esteban‐Cornejo, Oscar L. López, Beth E. Snitz, Sarah Berman, Robert A. Sweet, Thomas K. Karikari	1
5	Aquaporin‐4: Unraveling the Link Between Reactive Astrogliosis and Neuroinflammation in Down syndrome with Alzheimer’s Disease Pathogenesis 2024 ·Alzheimer s & Dementia ·(unknown), (unknown), (unknown), (unknown), Elizabeth J. Andrews, Florence Lai, Miloš D. Ikonomović, Julia Kofler, (unknown), Michael Phelan, Elizabeth Head	2
6	Advancements in High‐Resolution MRI Postmortem brain imaging: Histological examination on cells exclusively exhibiting White Matter Hyperintensities made possible using a novel, 3D printed, reusable, imaging container and cutting guide 2024 ·Alzheimer s & Dementia ·(unknown), Jinghang Li, (unknown), Jr‐Jiun Liou, (unknown), Tales Santini, Minjie Wu, Joseph Mettenburg, Howard Aizenstein, Miloš D. Ikonomović, Julia Kofler, Tamer S. Ibrahim	0
7	Application of robust regression in translational neuroscience studies with non-Gaussian outcome data 2024 ·Frontiers in Aging Neuroscience ·Michael Malek‐Ahmadi, Stephen D. Ginsberg, Melissa J. Alldred, Scott Counts, Miloš D. Ikonomović, Eric E. Abrahamson, Sylvia E. Perez, Elliott J. Mufson	1
8	Biostatistical Estimation of Tau Threshold Hallmarks (BETTH) Algorithm for Human Tau PET Imaging Studies 2023 ·Journal of Nuclear Medicine ·Alexandra Gogola, Brian J. Lopresti, Dana Tudorascu, Beth E. Snitz, Davneet Minhas, Vincent Doré, Miloš D. Ikonomović, C. Elizabeth Shaaban, (unknown), Pierrick Bourgeat, N. Scott Mason, Howard Aizenstein, Chester A. Mathis, William E. Klunk, Christopher C. Rowe, Oscar L. López, Ann D. Cohen, Victor L. Villemagne, (unknown)	8
9	Aldo-Keto Reductase 1C15 Characterization and Protection in Ischemic Brain Injury 2023 ·Antioxidants ·Tuo Yang, Qianqian Li, (unknown), (unknown), Miloš D. Ikonomović, Feng Zhang	5
10	Blood‐brain barrier neuropathology in individuals with Down syndrome and Alzheimer’s disease 2023 ·Alzheimer s & Dementia ·Lisi Flores Aguilar, (unknown), Julia Kofler, Miloš D. Ikonomović, Florence Lai, Adam M. Brickman, Elizabeth Head	0
11	Preclinical modelling of militarily relevant traumatic brain injuries: Challenges and recommendations for future directions 2017 ·Brain Injury ·Ibolja Černak, Donald G. Stein, Gregory A. Elder, (unknown), Kenneth C. Curley, Ralph G. DePalma, John E. Duda, Miloš D. Ikonomović, Grant L. Iverson, Firas Kobeissy, Vassilis E. Koliatsos, (unknown), Anthony Pacifico, Douglas H. Smith, Raymond A. Swanson, Floyd J. Thompson, Frank C. Tortella	26
12	Small-molecule PET Tracers for Imaging Proteinopathies 2017 ·Seminars in Nuclear Medicine ·Chester A. Mathis, Brian J. Lopresti, Miloš D. Ikonomović, William E. Klunk	89
13	Hippocampal Endosomal, Lysosomal, and Autophagic Dysregulation in Mild Cognitive Impairment 2015 ·Journal of Neuropathology & Experimental Neurology ·Sylvia E. Perez, Bin He, Muhammad Nadeem, Joanne Wuu, Stephen D. Ginsberg, Miloš D. Ikonomović, Elliott J. Mufson	42
14	Using Pittsburgh Compound B for In Vivo PET Imaging of Fibrillar Amyloid-Beta 2012 ·Advances in pharmacology ·Ann D. Cohen, Gil D. Rabinovici, Chester A. Mathis, William J. Jagust, William E. Klunk, Miloš D. Ikonomović	76
15	Anti-Amyloid Effects of Small Molecule Aβ-Binding Agents in PS1/APP Mice 2009 ·Letters in Drug Design & Discovery ·Ann D. Cohen, Miloš D. Ikonomović, Eric E. Abrahamson, William R. Paljug, Steven T. DeKosky, Iliya Lefterov, Radosveta Koldamova, Shao Li, Mira Debnath, N. Scott Mason, Chester A. Mathis, William E. Klunk	23
16	X‐34 Labeling of Abnormal Protein Aggregates During the Progression of Alzheimer's Disease 2006 ·Methods in enzymology on CD-ROM/Methods in enzymology ·Miloš D. Ikonomović, Eric E. Abrahamson, Barbara A. Isanski, Manik L. Debnath, Chester A. Mathis, Steven T. DeKosky, William E. Klunk	45
17	Acetylcholinesterase changes in people with mild cognitive impairment implications for hippocampal plasticity 2002 ·Miloš D. Ikonomović, Elliott J. Mufson, Elizabeth J. Cochran, Derrick Bennett, Steven T. DeKosky	2
18	Upregulation of choline acetyltransferase activity in hippocampus and frontal cortex of elderly subjects with mild cognitive impairment breakdown → 2002 ·Annals of Neurology ·Steven T. DeKosky, Miloš D. Ikonomović, Scot Styren, Laurel Beckett, Stephen R. Wisniewski, David A. Bennett, Elizabeth J. Cochran, Jeffrey H. Kordower, Elliott J. Mufson	560
19	GABAA receptor β2 and β3 subunits mRNA in the hippocampal formation of aged human brain with Alzheimer-related neuropathology 1998 ·Molecular Brain Research ·Katsuyoshi Mizukami, Dennis R. Grayson, Miloš D. Ikonomović, Roxanne Sheffield, David M. Armstrong	35
20	AMPA‐selective glutamate receptor subtype immunoreactivity in the hippocampal formation of patients with Alzheimer's disease 1995 ·Hippocampus ·Miloš D. Ikonomović, Roxanne Sheffield, David M. Armstrong	42

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact